The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Javitt Jonathan C since 2008.
This trader's CIK number is 1303782.
At the time of last reporting, Javitt Jonathan C was the Chairman and Chief Scientist of Nrx Pharmaceuticals, Inc.. (stock ticker symbol NRXP).
Also see all insider trading activities at Nrx Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | BCLI | 0 | $0 | 40,000 | $10,000 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | NRXP | 40,000 | $46,800 | 0 | $0 | 0 | $0 |
| 2023 | NRXP | 300,000 | $97,400 | 0 | $0 | 0 | $0 |
| 2022 | NRXP | 100,000 | $5,800,000 | 0 | $0 | 0 | $0 |
1. Brainstorm Cell Therapeutics Inc. (BCLI)
2. Nrx Pharmaceuticals, Inc. (NRXP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-08-27 | BCLI | Sale | 40,000 | .25 | 10,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-17 | NRXP | Buy | 40,000 | 1.17 | 46,800 |
| 2023-08-23 | NRXP | Buy | 100,000 | .33 | 33,000 |
| 2023-08-22 | NRXP | Buy | 200,000 | .32 | 64,400 |
| 2022-06-01 | NRXP | Buy | 100,000 | 58.00 | 5,800,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Javitt Jonathan C (Chairman and Chief Scientist of Nrx Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.